J&J Independence iBOT Stair-Climbing Data Need Scrutiny, FDA Panel Says
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson/Independence Technology should prospectively evaluate user training for the Independence iBOT 3000 Advanced Mobility System specific to stair-climbing at home and test sites, FDA's Orthopaedic & Rehabilitation Devices Panel recommended Nov. 20 in Gaithersburg, Maryland